Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free)
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Knockout Tested Rabbit Recombinant Monoclonal TRIF antibody. Carrier free. Suitable for WB, IP and reacts with Human samples.
View Alternative Names
PRVTIRB, TRIF, TICAM1, TIR domain-containing adapter molecule 1, TICAM-1, Putative NF-kappa-B-activating protein 502H, Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta, MyD88-3, TIR domain-containing adapter protein inducing IFN-beta
- IP
Collaborator
Immunoprecipitation - Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free) (AB302563)
This data was developed using ab302562, the same antibody clone in a different buffer formulation.
Immunoprecipitation of TICAM1 in U-87 MG cells. Lysates were prepared and immunoprecipitation was performed using 2 μg of ab302562 pre-coupled to Protein A beads. Samples were then washed and processed for western blot.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Immunoprecipitation - Anti-TRIF (TICAM1) antibody [EPR24995-152] (<a href='/en-us/products/primary-antibodies/trif-ticam1-antibody-epr24995-152-ab302562'>ab302562</a>) at 2 µg
false
- IP
Supplier Data
Immunoprecipitation - Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free) (AB302563)
This data was developed using ab302562, the same antibody clone in a different buffer formulation.
TRIF (TICAM1) was immunoprecipitated from 0.35 mg Raji (human Burkitt's lymphoma b lymphocyte) whole cell lysate with ab302562 at 1/30 dilution (2 µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab302562 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-TRIF (TICAM1) antibody [EPR24995-152] (<a href='/en-us/products/primary-antibodies/trif-ticam1-antibody-epr24995-152-ab302562'>ab302562</a>) at 1/30 dilution
Lane 1:
Raji (human burkitt's lymphoma b lymphocyte) whole cell lysate
Lane 2:
<a href='/en-us/products/primary-antibodies/trif-ticam1-antibody-epr24995-152-ab302562'>ab302562</a> IP in Raji whole cell lysate
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free) (AB302563)
This data was developed using ab302562, the same antibody clone in a different buffer formulation.
Diluting and blocking buffer and concentration : 5% NFDM/TBST.
Lysates were freshly made and used for Western Blotting immediately to minimize protein degradation.
The identity of the lower MW band at approximately 18 kDa is unknown.
All lanes:
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (<a href='/en-us/products/primary-antibodies/trif-ticam1-antibody-epr24995-152-ab302562'>ab302562</a>) at 1/1000 dilution
Lane 1:
Ramos (human Burkitt's lymphoma b lymphocyte) whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 76 kDa
Observed band size: 98 kDa
false
Exposure time: 3min
- WB
Collaborator
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free) (AB302563)
This data was developed using ab302562, the same antibody clone in a different buffer formulation.
ab302562 was shown to react with TICAM1 in wild-type U-87 MG cells in Western blot with loss of signal observed in TICAM1 knockout cell line ab305279. Wild-type U-87 MG and TICAM1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab302562 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot at 1/1000 dilution
Lane 1:
Wild-type U-87 MG lysate at 30 µg
Lane 2:
Western blot - Human TICAM1 knockout U-87MG cell line (<a href='/en-us/products/cell-lines/human-ticam1-knockout-u-87mg-cell-line-ab305279'>ab305279</a>) at 30 µg
Lane 2:
TICAM1 knock-out U-87 MG lysate at 30 µg
false
- WB
Lab
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free) (AB302563)
Western blot : Anti-TICAM1 antibody [EPR24995-152] (ab302562) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab302562 was shown to bind specifically to TICAM1. A band was observed at 85 kDa in wild-type U-87 MG cell lysates with no signal observed at this size in TICAM1 knockout cell line. To generate this image, wild-type and TICAM1 knockout U-87 MG cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution. This data was developed using ab302562, the same antibody clone in a different buffer formulation.
Lanes 1 - 4:
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (<a href='/en-us/products/primary-antibodies/trif-ticam1-antibody-epr24995-152-ab302562'>ab302562</a>) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free) (ab302563)
Lane 1:
Wild-type U-87 MG cell lysate at 20 µg
Lane 2:
TICAM1 knockout U-87 MG cell lysate at 20 µg
Lane 3:
Raji cell lysate at 20 µg
Lane 4:
HL-60 cell lysate at 20 µg
Observed band size: 85 kDa
false
- WB
Supplier Data
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free) (AB302563)
This data was developed using ab302562, the same antibody clone in a different buffer formulation.
Diluting and blocking buffer and concentration : 5% NFDM/TBST.
Lysates were freshly made and used for Western Blotting immediately to minimize protein degradation.
Negative control : HL-60.
All lanes:
Western blot - Anti-TRIF (TICAM1) antibody [EPR24995-152] (<a href='/en-us/products/primary-antibodies/trif-ticam1-antibody-epr24995-152-ab302562'>ab302562</a>) at 1/1000 dilution
Lane 1:
Raji (human Burkitt's lymphoma b lymphocyte) whole cell lysate at 20 µg
Lane 2:
HL-60 (human acute promyelocytic leukemia promyeloblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 76 kDa
Observed band size: 98 kDa
false
Exposure time: 59s
Related conjugates and formulations (1)
-
Anti-TRIF (TICAM1) antibody [EPR24995-152]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TRIF is part of the innate immune response mechanism. It functions as a central component in signal transduction processes especially in response to pathogen-associated molecular patterns (PAMPs). TRIF often forms complexes with other signaling proteins to activate transcription factors such as IRF3 and NF-kB which stimulate the expression of inflammatory cytokines and antiviral genes. This function allows the body to respond quickly to infections and initiate immune defenses.
Pathways
TRIF participates in important immune signaling pathways notably the TLR and interferon signaling pathways. In the TLR pathway TRIF interacts with proteins such as MyD88 and TRAF6 to propagate signals from TLR4 critical in detecting Gram-negative bacteria. Through its role in the interferon signaling pathway TRIF helps in the regulation of antiviral responses and is essential for the expression of interferon-stimulated genes that combat viral infections.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com